Kluster Kepakaran/ Cluster of Expertise :
Kesihatan dan Perubatan Termaju,
Biografi/ Biography :
Dr. Kok-Yong Chin adalah seorang pensyarah kanan di Jabatan Farmakologi, Fakulti Perubatan, Universiti Kebangsaan Malaysia. Minat penyelidikannya merangkumi epidemiologi kesihatan tulang, penuaan lelaki, metabolisme tulang, dan penggunaan vitamin E dalam merawat penyakit muskuloskeletal. Beliau adalah pengarang/bersama pengarang lebih daripada 220 artikel jurnal. Indeks h beliau kini berada pada 39, menurut Scopus. Beliau memenangi Anugerah Penyelidik Muda di Persidangan Ke-32 Persatuan Farmakologi dan Fisiologi Malaysia pada tahun 2018, Persidangan Ke-5 Persekutuan Osteoporosis Asia pada tahun 2017, dan Persidangan International Conference on Advances in Medical Science pada tahun 2015. Beliau juga merupakan wakil Malaysia di Mesyuarat Pemenang Nobel Lindau ke-65 pada tahun 2015. Kini, beliau berkhidmat sebagai editor akademik untuk Journal of Tropical Life Science, editor bersekutu untuk BMC Public Health dan Frontiers in Endocrinology, serta ahli lembaga editorial untuk Medicine & Health. Beliau disenaraikan sebagai 2% saintis yang paling banyak dirujuk oleh Elsevier pada tahun 2021-2023.
Dr Kok-Yong Chin is a senior lecturer at the Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia. His research interests include the epidemiology of bone health, male ageing, bone metabolism and the use of vitamin E in treating musculoskeletal diseases. He is the author/coauthor of more than 220 journal articles. His h-index currently stands at 39, according to Scopus. He won the Young Investigator Award at the 32nd Malaysian Society of Pharmacology and Physiology in 2018, the 5th Asian Federation of Osteoporosis Society Meeting in 2017, and the 1st International Conference of Advances in Medical Science in 2015. He was also a representative of Malaysia at the 65th Lindau Nobel Laureate Meeting in 2015. He currently serves as an academic editor of the Journal of Tropical Life Science, associate editor of BMC Public Health and Frontiers in Endocrinology, and an editorial board member of Medicine & Health. He is listed as the top 2% most cited scientist by Elsevier in 2021-2023.
muhamad riduan daud, petrick periyasamy, kok-yong chin, najma kori, ummu afeera zainulabid, sheng qian yew, nur ezzaty mohammad kazmin, xiong khee cheong. (2026). low bone mineral density in men living with hiv on tenofovir antiretroviral therapy: a cross-sectional exploratory study from a malaysian tertiary hospital. - tropical medicine and infectious disease. 1 - 14.
kok-yong chin. (2026). vitamin k2 as a bone protective bioactive against osteoporosis and fragility fracture. - advances in biochemistry in health and d. 437 - 458.
yuanzhong wang, guiju chen, qin wang, bilin liu, qi he, xia huang, kok-yong chin. (2026). traditional medicine in a modern light: a scoping review on the osteoprotective potential of eucommia ulmoides. - frontiers in pharmacology. 1 - 19.
shabbir adnan shakir, kok-yong chin. (2026). effects of cannabidiol on bone health: a comprehensive scoping review. - biomedicines. 1 - 23.
nor amira nabila amir razak, jo aan goon, wan zurinah wan ngah, suzana makpol, nor faeizah ibrahim, nur fathiah abdul sani, kok yong chin, amilia aminuddin, mohd heikal mohd yunus, munirah md mansor. (2026). third interim report for a randomized, double-blinded, placebo-controlled study to evaluate the efficacy of oral supplementation of tocotrienol rich fraction (davoslife e3 complete). - . .
muhamad riduan daud, petrick periyasamy, kok-yong chin, najma kori, ummu afeera zainulabid, sheng qian yew, nur ezzaty mohammad kazmin, xiong khee cheong. (2026). low bone mineral density in men living with hiv on tenofovir antiretroviral therapy: a cross-sectional exploratory study from a malaysian tertiary hospital. - tropical medicine and infectious disease. 1 - 14.
yuanzhong wang, guiju chen, qin wang, bilin liu, qi he, xia huang, kok-yong chin. (2026). traditional medicine in a modern light: a scoping review on the osteoprotective potential of eucommia ulmoides. - frontiers in pharmacology. 1 - 19.
shabbir adnan shakir, kok-yong chin. (2026). effects of cannabidiol on bone health: a comprehensive scoping review. - biomedicines. 1 - 23.
wei-zheng zhang, jin-qian han, kok-yong chin, roshaya zakaria and nor haty hassan. (2025). determinants of health-related quality of life after transarterial chemoembolization in hepatocellular carcinoma patients: a systematic review. - journal of clinical medicine. 1 - 17.
yuanzhong wang, guiju chen, xia ji, sok kuan wong, sophia ogechi ekeuku & kok-yong chin. (2025). ejiao as a preventive agent for osteoporosis - a scoping review of current evidence. - journal of orthopaedic surgery and research. 1 - 16.
wenjian zhao, weizheng zhang, kok-yong chin, xiaodong ma, hashwin singh tejpal singh, sophia ogechi ekeuku, yuanzhong wang, xia ji, yang guo, sok kuan wong, norliza muhammad, teh rohaila jamil, saharuddin ahmad. (2026). adiposity indices and bone health amongst malaysian adults: evidence from a cross-sectional study. - experimental and therapeutic medicine. 1 - 8.
siti norain azahar, chin kok yong, nur azlina mohd fahami, ibrahim abdel aziz ibrahim. (2025). pathogenesis of alcoholic fatty liver disease: molecular and cellular changes. - malaysian journal of pathology. 377 - 400.
yuanzhong wang, guiju chen, qin wang, zaifu zhou, wenjian zhao, sok kuan wong, tao wang, kok-yong chin. (2025). a comprehensive review of traditional chinese medicine ejiao (colla corii asini): chemical composition, quality control, and pharmacological actions. - natural product communications. 1 - 18.
lee, yee xin; lim, see meng; ng, xin qian; lum, pei teng; ramli, elvy suhana mohd; chin, kok-yong; budin, siti balkis. (2025). effects of low-protein diet on renal oxidative stress, biochemistry and histology in weaned rats. - sains malaysiana. 815 - 826.
abdullah al lawati, lubna al hashmi, husain al aswami, abdulrahman al hadhrami, kok-yong chin, srinivasa rao sirasanagandla, srijit das. (2024). deleterious biological effects of endocrine disruptors: an insight into human health risks. - endocrine, metabolic & immune disorders-drug targets. 1471 - 1479.
muhamad riduan daud, petrick periyasamy, kok-yong chin, najma kori, ummu afeera zainulabid, sheng qian yew, nur ezzaty mohammad kazmin, xiong khee cheong. (2026). low bone mineral density in men living with hiv on tenofovir antiretroviral therapy: a cross-sectional exploratory study from a malaysian tertiary hospital. - tropical medicine and infectious disease. 1 - 14.
yuanzhong wang, guiju chen, qin wang, bilin liu, qi he, xia huang, kok-yong chin. (2026). traditional medicine in a modern light: a scoping review on the osteoprotective potential of eucommia ulmoides. - frontiers in pharmacology. 1 - 19.
shabbir adnan shakir, kok-yong chin. (2026). effects of cannabidiol on bone health: a comprehensive scoping review. - biomedicines. 1 - 23.
wenjian zhao, weizheng zhang, kok-yong chin, xiaodong ma, hashwin singh tejpal singh, sophia ogechi ekeuku, yuanzhong wang, xia ji, yang guo, sok kuan wong, norliza muhammad, teh rohaila jamil, saharuddin ahmad. (2026). adiposity indices and bone health amongst malaysian adults: evidence from a cross-sectional study. - experimental and therapeutic medicine. 1 - 8.
yuanzhong wang, guiju chen, xia ji, sok kuan wong, sophia ogechi ekeuku & kok-yong chin. (2025). ejiao as a preventive agent for osteoporosis - a scoping review of current evidence. - journal of orthopaedic surgery and research. 1 - 16.
kok-yong chin. (2026). vitamin k2 as a bone protective bioactive against osteoporosis and fragility fracture. - advances in biochemistry in health and d. 437 - 458.
norazlina mohamed, norliza muhammad, noor azah abdul aziz, nor aini jamil @ a. wahab, mohd rizal abdul manaf, chan chin yi. (2024). kesedaran masyarakat terhadap kesihatan tulang dan sindrom metabolik. - . 37 - 42.
chin kok yong, ima nirwana soelaiman, fairus ahmad, wong sok kuan, ng pei yuen & shaanthana subramaniam. (2024). osteoporosis dan hubungkaitnya dengan sindrom metabolik. - . 27 - 36.
norzana abdul ghafar, norliza muhammad, yogeswaran lokanathan, chin kok yong & wong sok kuan. (2024). penuaan dan penyakit degeneratif. - . 14 - 26.
norazlina mohamed, chin kok yong. (2024). kaedah penuaan sihat secara saintifik. - . 11 - 13.
norazlina mohamed, chin kok yong. (2024). kaedah penuaan sihat secara saintifik. - . 11 - 13.
norazlina mohamed, chin kok yong. (2024). penyakit degeneratif dan kaedah intervensi inovatif. - . .
fairus ahmad, chin kok yong, khairun-nisa hashim. (2024). sesudu madu kelulut merahmati kesihatan. - . .
norazlina mohamed, norliza muhammad, noor azah abdul aziz, nor aini jamil @ a. wahab, mohd rizal abdul manaf, chan chin yi. (2024). kesedaran masyarakat terhadap kesihatan tulang dan sindrom metabolik. - . 37 - 42.
chin kok yong, ima nirwana soelaiman, fairus ahmad, wong sok kuan, ng pei yuen & shaanthana subramaniam. (2024). osteoporosis dan hubungkaitnya dengan sindrom metabolik. - . 27 - 36.
nor amira nabila amir razak, jo aan goon, wan zurinah wan ngah, suzana makpol, nor faeizah ibrahim, nur fathiah abdul sani, kok yong chin, amilia aminuddin, mohd heikal mohd yunus, munirah md mansor. (2026). third interim report for a randomized, double-blinded, placebo-controlled study to evaluate the efficacy of oral supplementation of tocotrienol rich fraction (davoslife e3 complete). - . .
nur-vaizura mohamad, tan see-xuan, melissa sia yun-shan, nur-adibah ismail, chin kok-yong . (2025). therapeutic effects of palm tocotrienol on bone and hormonal profiles in ovariectomised rats. - asian regional conference on systems biology x international conference on natural products 2025. .
siti nor amira mohd azli1, nurul husnina mohd khairul zain, wan zurinah wan ngah, jo aan goon, norwahidah abdul karim, kok yong chin, jen kit tan, amilia aminuddin, munirah md mansor, mohd heikal mohd yunus, yee wei ung, wei ney yap, hsieu yen loong, nur fathiah abdul sani and suzana makpol. (2025). association between body mass index and hemodynamic indicators in normal healthy middle-aged adults . - international palm oil congress and exhibition 2025 . .
mohd azli, s.n.a., mohd khairul zain, n.h., wan ngah, w.z., goon, j.a., damanhuri, h., abdul karim, n., chin, k.y., tan, j.k., aminuddin, a., md mansor, m., mohd yunus, m.h., ung, y.w., yap, w.n., loong, h.y., abdul sani, f., makpol, s.. (2025). effect of body mass index on bone mineral density in middle-aged adults. - postgraduate research conference 2025 . .
mohd khairul zain nh, mohd azli sna, makpol s, wan ngah wz, goon ja, damanhuri h, abdul karim n, chin ky, tan jk, aminuddin a, md mansor m, mohd yunus mh, ung yw, yap wn, loong mhy, abdul sani nf. (2025). effects of tocotrienol-rich fraction on dietary intake and body composition: interim findings from a double-blind randomised controlled trial. - 27th medical & health research week 'upholding credibility in an evolving research landscape'. .
| Geran / Grant | Kolaborator / Collaborator | Status |
|---|---|---|
| INVESTIGATING THE GUT-LUNG AXIS INTERACTION OF LIGNOSUS RHINOCEROTIS (TIGER MILK MUSHROOM) IN REDUCING COUGH AND LUNG INFLAMMATION | nexus wise sdn bhd | 69.5% (2024-01-31 sehingga 2026-12-31) |
| TOCOTRIENOL AS A SENOLYTIC AGENT: A PHASE 2 CLINICAL TRIAL | malaysian palm oil board | 76.7% (2022-11-29 sehingga 2027-01-30) |
| TOCOTRIENOL AS A SENOLYTIC AGENT: A PHASE 2 CLINICAL TRIAL | davos life science sdn bhd | 76.7% (2022-11-29 sehingga 2027-01-30) |
| KESAN KETOKSIKAN BAHAN PSIKOAKTIF BAHARU (NPS) TERPILIH TERHADAP ORGAN UTAMA FUNGSI TUBUH | jabatan siasatan jenayah narkotik, polis diraja malaysia | 45.3% (2024-10-01 sehingga 2027-09-30) |
| ELUCIDATING THE EFFECT OF MITOCHONDRIA FUNCTION ON METABOLOMIC AND LIPIDOMIC CHANGES IN THE LIVER DURING AGEING AND ITS MODULATION BY GINGER EXTRACT | genomax technologies sdn bhd | 69.2% (2025-01-28 sehingga 2026-07-27) |
| INVESTIGATING THE EFFECTS OF DELTA-TOCOTRIENOL AND VITAMIN K2 CO-SUPPLEMENTATION IN PREVENTING OSTEOPOROSIS IN A RAT MODEL OF OESTROGEN DEFICIENCY | american river nutrition | 69.2%(2024-11-01 sehingga 2026-10-31) |
| THE EFFECT OF PALM TOCOTRIENOL RICH FRACTION ON ALCOHOLIC FATTY LIVER DISEASE (AFLD): A PHASE II CLINICAL TRIAL | malaysian palm oil board (mpob) | 69.2%(2021-11-11 sehingga 2026-12-15) |
| THE EFFECT OF PALM TOCOTRIENOL RICH FRACTION ON ALCOHOLIC FATTY LIVER DISEASE (AFLD): A PHASE II CLINICAL TRIAL | excelvite sdn. bhd | 69.2%(2021-11-11 sehingga 2026-12-15) |
| THE EFFECT OF PALM TOCOTRIENOL RICH FRACTION ON ALCOHOLIC FATTY LIVER DISEASE (AFLD): A PHASE II CLINICAL TRIAL | hovid berhad | 69.2%(2021-11-11 sehingga 2026-12-15) |
BASIC MEDICAL SCIENCES :CLINICAL AND HEALTH SCIENCES
Osteoporosis
Pengalaman / Experience : tahun/years(s)
PHARMACOLOGY :CLINICAL AND HEALTH SCIENCES
Osteoporosis
Pengalaman / Experience : tahun/years(s)
PHARMACOLOGY :CLINICAL AND HEALTH SCIENCES
Osteoporosis and Bone Metabolism
Pengalaman / Experience : 5 tahun/years(s)
BASIC MEDICAL SCIENCES :CLINICAL AND HEALTH SCIENCES
Animal models of osteoporosis, osteoarthritis
Pengalaman / Experience : 5 tahun/years(s)